MorphoSys AG Total Shareholders Equity 2011-2026 | MOR

Annual Total Shareholders Equity MorphoSys AG

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	621 M	395 M	488 M	359 M	415 M	-	-	-	-	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
621 M	359 M	456 M

Quarterly Total Shareholders Equity MorphoSys AG

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	245 M	-	-	-	621 M	-	-	-	395 M	-	-	-	488 M	-	-	-	360 M	-	-	-	415 M	-	-	-	363 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
621 M	245 M	412 M

Total Shareholders Equity of other stocks in the Biotechnology industry

Issuer	Total Shareholders Equity	Price	% 24h	Market Cap	Country
Aligos Therapeutics ALGS	53.5 M	$ 8.64	8.07 %	$ 85.4 M	USA
Alterity Therapeutics Limited ATHE	35.5 M	$ 3.66	-1.48 %	$ 8.81 B	Australia
I-Mab IMAB	1.72 B	-	-	$ 866 M	China
AlloVir ALVR	78.8 M	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	60.8 M	-	-	$ 10.1 M	USA
Genfit SA GNFT	-16.2 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	2.27 M	-	-13.47 %	$ 169 M	France
Applied Therapeutics APLT	-17.1 M	-	-	$ 8.42 M	USA
Midatech Pharma plc MTP	6.72 M	-	-18.52 %	$ 27.3 M	Britain
Amphastar Pharmaceuticals AMPH	789 M	$ 21.36	4.86 %	$ 998 M	USA
Acorda Therapeutics ACOR	-158 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	70.7 M	-	-	$ 86.2 M	USA
Advaxis ADXS	-24.4 M	-	-9.65 %	$ 45.9 M	USA
AgeX Therapeutics AGE	-37 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	715 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	32.6 M	$ 1.47	5.0 %	$ 378 M	USA
Applied Genetic Technologies Corporation AGTC	29.5 M	-	-	$ 26.5 M	USA
Allakos ALLK	169 M	-	-	$ 28.6 M	USA
Aptinyx APTX	38.3 M	-	-39.0 %	$ 4.57 M	USA
Can-Fite BioPharma Ltd. CANF	5.59 M	$ 2.92	-	$ 4.81 M	Israel
Aquestive Therapeutics AQST	-33.7 M	$ 4.19	2.7 %	$ 448 M	USA
Aravive ARAV	10.7 M	-	-13.39 %	$ 1.45 M	USA
Arcutis Biotherapeutics ARQT	189 M	$ 24.12	-0.37 %	$ 3.07 B	USA
AIkido Pharma AIKI	69.4 M	-	1.93 %	$ 17.4 M	USA
Celldex Therapeutics CLDX	527 M	$ 32.59	1.09 %	$ 2.16 B	USA
Autolus Therapeutics plc AUTL	178 M	$ 1.47	-1.34 %	$ 391 M	Britain
Aptose Biosciences APTO	-27.2 M	-	-45.71 %	$ 1.2 M	Canada
Cidara Therapeutics CDTX	163 M	-	-	$ 1.41 B	USA
AVROBIO AVRO	94.7 M	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	-1.1 M	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	15.6 B	-	-	$ 96.9 B	Britain
Akero Therapeutics AKRO	750 M	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	688 M	-	-	$ 867 M	Germany
Brainstorm Cell Therapeutics BCLI	-9.98 M	-	-2.5 %	$ 5.88 M	USA
BeiGene, Ltd. BGNE	4.36 B	-	0.49 %	$ 251 B	Cayman-islands
Akouos AKUS	234 M	-	0.23 %	$ 488 M	USA
Akari Therapeutics, Plc AKTX	28.3 M	$ 4.25	8.35 %	$ 286 B	Britain
Allena Pharmaceuticals ALNA	18.9 M	-	3.16 %	$ 1.9 M	USA
Esperion Therapeutics ESPR	-302 M	$ 2.22	2.3 %	$ 461 M	USA
Evogene Ltd. EVGN	56.9 M	$ 0.82	1.13 %	$ 27.9 M	Israel
Baudax Bio BXRX	-24.2 M	-	0.59 %	$ 63 K	USA
Cabaletta Bio CABA	112 M	$ 3.2	2.24 %	$ 322 M	USA
Alpine Immune Sciences ALPN	179 M	-	-	$ 2.17 B	USA
CymaBay Therapeutics CBAY	292 M	-	-	$ 3.45 B	USA
Aileron Therapeutics ALRN	16.9 M	-	10.36 %	$ 9.8 M	USA